VICKI CHACON: Open Payments
NPI 1750922233 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 36 payments from 7 companies in 2025. Trend: 2023 $830 · 2024 $1,109 · 2025 $671
Food & beverage: $671
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 6 | $198 |
| ABBVIE INC. | 19 | $170 |
| Supernus Pharmaceuticals, Inc. | 3 | $124 |
| E.R. Squibb & Sons, L.L.C. | 3 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Tris Pharma Inc | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: VRAYLAR, Qelbree, FANAPT, HETLIOZ, COBENFY, CAPLYTA, Dyanavel XR, REXULTI.
Industry payments across SC — which companies pay providers there.
